QRS CARD S-T SEGMENT ANALYSIS PATIENT MONITORING SYSTEM MODEL: QRS CARD USB— 510(k) K100813

Name: FDA 510(k) clearance K100813
Creator: U.S. Food and Drug Administration
Published: 2010-07-23

Substantially Equivalent

Pulse Biomedical, Inc.

FDA 510(k) clearance K100813 for QRS CARD S-T SEGMENT ANALYSIS PATIENT MONITORING SYSTEM MODEL: QRS CARD USB, Substantially Equivalent on 2010-07-23. Applicant: Pulse Biomedical, Inc.. Device class: 2.

Clearance details

Applicant: Pulse Biomedical, Inc.
Product code: Code DPS
Device class: Class 2
Regulation: 21 CFR 870.2340
Advisory panel: Cardiovascular
Date received: 2010-03-23
Decision date: 2010-07-23
Decision: Substantially Equivalent
Clearance type: Special
Location: Norristown, PA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code DPS

view all

K252463 — SE-1202 Series Electrocardiograph (Model: SE-1202, SE-1202E)2026-07-02
K251670 — MAC 7 Resting ECG Analysis System2026-01-26
K252361 — AccurECG Analysis System (v2.0)2025-12-22
K252474 — Withings BeamO (SCT02)2025-11-10
K250569 — Cardiologs Holter Platform2025-08-06

More clearances from Pulse Biomedical, Inc.

view all

K042799 — QRS-CARD CARDIOLOGY SUITE2004-10-22
K972255 — PULSE BIOMEDICAL INC, QRS CARD S-T SEGMENT ANALYSIS MONITORING SYSTEM1998-07-07

Adverse events under product code DPS

product code DPS

Death: 7
Total: 7

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.